Appropriation Veto Threat Centers On Opioid Language In FDA Budget
This article was originally published in The Tan Sheet
Executive Summary
The White House likely is concerned about the potential precedent from a provision in the House bill that would link FDA funding to release of guidance. OMB says it opposes provisions that “unduly interfere” with the FDA rulemaking process.